{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:11:53Z","timestamp":1781205113022,"version":"3.54.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.00387","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:20:07Z","timestamp":1596194407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of Imiquimod on Tachyzoites of Toxoplasma gondii and Infected Macrophages in vitro and in BALB\/c Mice"],"prefix":"10.3389","volume":"10","author":[{"given":"Leila","family":"Zaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghaffarifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Sadraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J. Infect. Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1128\/AAC.45.4.1137-1142.2001","article-title":"Identification of genes induced by a macrophage activator, S-28463, using gene expression array analysis","volume":"45","author":"Buates","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/cid\/ciu168","article-title":"Topical application of imiquimod as a treatment for chromoblastomycosis","volume":"58","author":"de Sousa","year":"2014","journal-title":"Clin. Infect. Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/jac\/48.6.751","article-title":"Imiquimod and resiquimod as novel immunomodulators","volume":"48","author":"Dockrell","year":"2001","journal-title":"J. Antimicrob. Chemother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1017\/S0031182020000451","article-title":"White-tailed deer (Odocoileus virginianus) are a reservoir of a diversity of Toxoplasma gondii strains in the USA and pose a risk to consumers of undercooked venison","volume":"147","author":"Dubey","year":"2020","journal-title":"Parasitology"},{"key":"B6","first-page":"986","article-title":"Apoptotic effect of morphine, imiquimod and nalmefene on promastigote, infected and uninfected macrophages with amastigote of Leishmania major by flow cytometry","volume":"17","author":"Ebrahimisadr","year":"2018","journal-title":"Iran J. Pharm. Res"},{"key":"B7","first-page":"202","article-title":"Evaluation of the effect of morphine and imiquimodon expression of TLR2 and TLR4 from lesion RNA extracted from BALB\/c mice infected with leishmania major","volume":"11","author":"Ebrahimisadr","year":"2019","journal-title":"Avicenna J. Med. Biotechnol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/21691401.2018.1457042","article-title":"The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB\/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome","volume":"46","author":"Emami","year":"2018","journal-title":"Artif Cells Nanomed. Biotechnol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jogoh.2017.12.003","article-title":"An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection","volume":"47","author":"Fallahi","year":"2018","journal-title":"J. Gynecol. Obstet. Hum. Reprod"},{"key":"B10","doi-asserted-by":"publisher","first-page":"a015669","DOI":"10.1101\/cshperspect.a015669","article-title":"Opportunistic infections\u2014coming to the limits of immunosuppression?","volume":"3","author":"Fishman","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.17179\/excli2018-1993","article-title":"Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii","volume":"18","author":"Foroutan","year":"2019","journal-title":"EXCLI J"},{"key":"B12","first-page":"259","article-title":"Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii","volume":"18","author":"Foroutan","year":"2019","journal-title":"EXCLI J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies","volume":"50","author":"Geisse","year":"2004","journal-title":"J. Am. Acad. Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1179\/1364859411Y.0000000022","article-title":"Detection of IgM and IgG anti-Toxoplasma antibodies in renal transplant recipients using ELFA, ELISA and ISAGA methods: comparison of pre-and post-transplantation status","volume":"105","author":"Gharavi","year":"2011","journal-title":"Ann. Trop. Med. Parasitol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1005396","DOI":"10.1371\/journal.ppat.1005396","article-title":"The diverse role of NK cells in immunity to Toxoplasma gondii infection","volume":"12","author":"Gigley","year":"2016","journal-title":"PLoS Pathog"},{"key":"B16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88\u2013dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat. Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e00053","DOI":"10.1016\/j.fawpar.2019.e00053","article-title":"A one health approach to vaccines against Toxoplasma gondii","volume":"15","author":"Innes","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.18502\/ijpa.v14i3.1478","article-title":"Evaluation of morphine with imiquimod as opioid growth factor receptor or nalmefene as opioid blocking drug on leishmaniasis caused by leishmania major in vitro","volume":"14","author":"Jabari","year":"2019","journal-title":"Iran J. Parasitol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1517\/14712598.2014.945415","article-title":"Therapeutic vaccines for leishmaniasis","volume":"14","author":"Khamesipour","year":"2014","journal-title":"Expert Opin. Biol. Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1128\/AAC.00462-10","article-title":"Activity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds","volume":"54","author":"Maubon","year":"2010","journal-title":"Antimicrob. Agents Chemother"},{"key":"B21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.22038\/nmj.2020.07.04","article-title":"Liposomes containing the imiquimod adjuvant as a vaccine in the cutaneous leishmaniasis model","volume":"7","author":"Mehravaran","year":"2020","journal-title":"Nanomed. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1371\/journal.ppat.1006351","article-title":"Toxoplasma gondii: entry, association, and physiological influence on the central nervous system","volume":"13","author":"Mendez","year":"2017","journal-title":"PLoS Pathog"},{"key":"B23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/0253-7613.178838","article-title":"Apoptotic activity and anti-Toxoplasma effects of artemether on the tachyzoites and experimental infected Vero and J774 cell lines by Toxoplasma gondii","volume":"48","author":"Mikaeiloo","year":"2016","journal-title":"Indian J. Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","article-title":"Review article imiquimod applied topically: a novel immune response modifier and new class of drug","volume":"21","author":"Miller","year":"1999","journal-title":"Int. J. Immunopharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1128\/AAC.01323-16","article-title":"Evaluation of propranolol effect on experimental acute and chronic toxoplasmosis using quantitative PCR","volume":"60","author":"Montazeri","year":"2016","journal-title":"Antimicrobial. Agents Chemotherapy"},{"key":"B26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/978-3-319-28797-3_43","article-title":"Toxoplasmosis after solid organ transplantation","volume-title":"Transplant Infections. 4th Edn","author":"Montoya","year":"2016"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0143087","DOI":"10.1371\/journal.pone.0143087","article-title":"Vaccination with recombinant microneme proteins confers protection against experimental toxoplasmosis in mice","volume":"10","author":"Pinzan","year":"2015","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/intimm\/dxy004","article-title":"Host immune responses to Toxoplasma gondii","volume":"30","author":"Sasai","year":"2018","journal-title":"Int. Immunol"},{"key":"B29","first-page":"3528","article-title":"Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine","volume":"52","author":"Sidky","year":"1992","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","article-title":"Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential","volume":"27","author":"Stanley","year":"2002","journal-title":"Clin. Exp. Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against Toxoplasma gondii","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/bjd.16267","article-title":"Lymphoedema in patients with lentigo maligna treated with imiquimod: a long-term adverse effect","volume":"178","author":"Tio","year":"2018","journal-title":"Br. J. Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fmicb.2017.00389","article-title":"Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol"},{"key":"B35","volume-title":"Methionine Enkephalin, A New Lymphokine for the Treatment of ARC Patients. Stress and Immunity","author":"Wybran","year":"1991"},{"key":"B36","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3181\/0802-RM-58","article-title":"Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function","volume":"233","author":"Zagon","year":"2008","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"514","DOI":"10.17179\/excli2019-1961","article-title":"Toxoplasma gondii: preventive and therapeutic effects of morphine and evaluation of treatment parameters of tachyzoites and infected macrophages in vitro and in a murine model","volume":"19","author":"Zaki","year":"2020","journal-title":"EXCLI J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1586\/14760584.2015.1098539","article-title":"Recent advances in developing vaccines against Toxoplasma gondii: an update","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert. Rev. Vaccines"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00387\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:20:12Z","timestamp":1596194412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00387\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":38,"alternative-id":["10.3389\/fcimb.2020.00387"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.00387","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"article-number":"387"}}